Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer). (CheckMate548)

Clinical Trial ID NCT02667587

PubWeight™ 2.32‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02667587

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Trial Watch: Immunotherapy plus radiation therapy for oncological indications. Oncoimmunology 2016 0.81
2 Current clinical trials testing the combination of immunotherapy with radiotherapy. J Immunother Cancer 2016 0.81
3 Combining Radiation Therapy with Immune Checkpoint Blockade for Central Nervous System Malignancies. Front Oncol 2016 0.78
Next 100